Paolo Marchetti

Pubblicazioni

Titolo Pubblicato in Anno
The sexist behaviour of immune checkpoint inhibitors in cancer therapy? ONCOTARGET 2017
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong JOURNAL OF THORACIC DISEASE 2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients JOURNAL OF CLINICAL ONCOLOGY 2017
Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report CLINICAL DRUG INVESTIGATION 2017
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer JOURNAL OF CELLULAR PHYSIOLOGY 2017
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study FRONTIERS IN IMMUNOLOGY 2017
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law PAIN MEDICINE 2017
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab MEDICAL ONCOLOGY 2017
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial ANNALS OF ONCOLOGY 2017
The factor structure and use of the Demoralization Scale (DS-IT) in Italian cancer patients PSYCHO-ONCOLOGY 2017
Positon paper of the Italian Associaton of Medical Oncology on early palliatve care in oncology practce (Simultaneous Care) TUMORI 2017
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer JOURNAL OF CELLULAR PHYSIOLOGY 2017
Dignity and Psychosocial-Related Variables in Advanced and Nonadvanced Cancer Patients by Using the Patient Dignity Inventory-Italian Version JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 2017
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate ANTI-CANCER DRUGS 2017
Brain Metastases: Surgical Treatment and Overall Survival WORLD NEUROSURGERY 2017
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients PHARMACOGENOMICS 2017
The use of fentanyl in pain management in head and neck cancer patients: a narrative review. BRITISH JOURNAL OF PAIN 2017
Being positive despite illness: the contribution of positivity to the quality of life of cancer patients PSYCHOLOGY & HEALTH 2016
Current challenges in HER2-positive breast cancer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2016
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy JOURNAL OF CLINICAL ONCOLOGY 2016

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma